Status:
COMPLETED
Exploring Unmet Needs and Attitudes to Skin Self-examination in Melanoma Survivors
Lead Sponsor:
Oxford University Hospitals NHS Trust
Collaborating Sponsors:
Barts & The London NHS Trust
Ninewells Hospital
Conditions:
Melanoma, Stage I
Melanoma Stage III
Eligibility:
All Genders
18-80 years
Brief Summary
This is a prospective, multi-centred cohort study whereby the EUNASS Study questionnaire will be administered electronically to identify needs of melanoma survivors, the extent to which these needs ar...
Eligibility Criteria
Inclusion
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 18 years or above.
- Histological diagnosis of primary cutaneous invasive melanoma (any Breslow thickness) at 3 - 12 months from diagnosis (as most primary treatment will be complete by 3 mths)
- American Joint Cancer Committee Version 8 \[2018\] (AJCC V8) Stage I - III melanoma at time of recruitment
- Able to complete an electronic questionnaire
Exclusion
- Other current active internal malignancy (i.e. does not include non-melanoma skin cancers)
- Inability to independently complete electronic questionnaire
- AJCC V8 Stage IV melanoma at time of recruitment
- Clinical stage of disease unknown / unconfirmed
Key Trial Info
Start Date :
November 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
252 Patients enrolled
Trial Details
Trial ID
NCT04675346
Start Date
November 18 2020
End Date
September 30 2022
Last Update
November 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Churchill Hospital
Headington, Oxford, United Kingdom, OX3 7LE